<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01088971</url>
  </required_header>
  <id_info>
    <org_study_id>CellBiotech</org_study_id>
    <nct_id>NCT01088971</nct_id>
  </id_info>
  <brief_title>Effect of Duolac 7S Administration on Improving Symptom in Irritable Bowel Syndrome</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cell Biotech Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cell Biotech Co., Ltd.</source>
  <brief_summary>
    <textblock>
      Gut microflora-mucosal interactions may be involved in the pathogenesis of irritable bowel
      syndrome (IBS). The purpose of this study is to investigate the efficacy of Duolac7S in
      changing the colonic microflora and improve the symptoms in IBS sufferers. In all, 64
      patients with Rome III positive diarrhea type IBS will complete a 6-week multiple centre
      controlled clinical trial. Patients will be randomized to receive either 2 capsules/day
      Duolac7S or 2 capsules/day placebo. IBS symptoms will be monitored and scored according to
      Likert scale. Changes in faecal microflora, stool frequency and form, quality of life (QOL)
      scores will be also monitored.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">July 2011</completion_date>
  <primary_completion_date type="Actual">July 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The improvement of IBS symptoms</measure>
    <time_frame>6 weeks (symptom diary and weekly questionnaire)</time_frame>
    <description>IBS symptoms were recorded on diary cards every evening during the treatment periods. Abdominal pain, discomfort,urgency and bloating were recorded (score 0-10); stool frequency as number of stools per day; stool consistency according to Bristol stool scale form (score 1-7).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in fecal microflora</measure>
    <time_frame>baseline and after 6weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes of biochemical marker</measure>
    <time_frame>baseline and after 6weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Irritable Bowel Syndrome</condition>
  <arm_group>
    <arm_group_label>Duolac 7S</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>starch capsule</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Duolac7S</intervention_name>
    <description>1 capsule two times everyday for 6 weeks</description>
    <arm_group_label>Duolac 7S</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>starch</intervention_name>
    <description>1capsule two times everyday for 6 weeks</description>
    <arm_group_label>starch capsule</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age: 18~65 years

          -  diarrhea type irritable bowel syndrome (by ROME III criteria)

          -  no organic bowel disease (by colonoscopy or barium enema)

        Exclusion Criteria:

          -  pregnant women or nursing mothers

          -  hypersensitivity to probiotics

          -  congestive heart failure or ischemic heart disease

          -  systolic blood pressure : more than 160 mmHg or diastolic blood pressure: more than
             100 mmHg

          -  uncontrolled diabetes mellitus, secondary dyslipidemia, hyperthyroidism, or
             hypothyroidism

          -  abdominal surgery (exception: appendectomy, hernia surgery)

          -  more than moderate alcohol drinking
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Yonsei University College of Medicine, Gangnam Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>135-720</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>December 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 7, 2010</study_first_submitted>
  <study_first_submitted_qc>March 16, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 18, 2010</study_first_posted>
  <last_update_submitted>December 22, 2011</last_update_submitted>
  <last_update_submitted_qc>December 22, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 23, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Irritable Bowel Syndrome</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>May 12, 2012</submitted>
    <returned>June 13, 2012</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

